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mechanisms regulating haematopoietic progenitor cells (HPCs) maintenance and self-renewal. Here, we report that murine bone
marrow HPCs activation by the vascular Notch Delta-4 ligandmaintains a significant proportion of cells specifically in the G0 state.
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432 C. Catelain et al.Introduction up-regulation of well-known self-renewal genes transcriptionHaematopoietic progenitor cells (HPCs) reside predomi-
nantly in the bone marrow (BM), where blood cell develop-
ment occurs. The BMmicroenvironment is a complex system
comprising nonhaematopoietic components such as bone-
forming cells including mesenchymal stem cells and osteo-
blasts, fibroblasts, adipocytes, innervation from the sym-
pathetic nervous system, reticular cells, pericytes, and
endothelial cells (Silberstein and Lin, 2013). It has long been
recognised that nonhaematopoietic BM-derived stroma
cells are capable of supporting long-term haematopoiesis
in vivo and in vitro (Frenette et al., 2013) and understand-
ing the precise mechanism by which niche cells interact to
regulate HPCs is critical for the development and improve-
ment of stem cell therapies based on HPC manipulation and
administration.
The initial discovery that functional alterations in osteo-
blastic cells had consequences on HPC function attracted the
interest of researchers in this field (Calvi et al., 2003) (Mansour
et al., 2012). A growing number of studies have subsequently
implicated bone marrow vasculature, which consists of a vast
network of thin-walled, fenestrated sinusoidal endothelial
cells and perivascular stromal cells as well as small arterioles,
in providing the proper milieu of prohaematopoietic factors
needed to support HPCs pool (Butler et al., 2010) (Ugarte and
Forsberg, 2013).
The role of Notch signalling in adult vertebrate HPCs
maintenance remained controversial, largely because gain-
and loss-of-function studies have not produced consistent
results. It has been suggested to be dispensable for adult
haematopoiesis through two complementary approaches
blocking the canonical Notch signalling within HPCs (one
with a dominant negative formof themastermind-like protein,
and the other inactivating the RBP-J gene) (Duncan et al.,
2005) (Maillard et al., 2008). However, recent studies support
a role for Notch in the regeneration of HPCs after injury (Butler
et al., 2010) (Varnum-Finney et al., 2011) andmore recently, a
role of endothelial Jagged-1 was highlighted for homeostatic
and regenerative haematopoiesis (Poulos et al., 2013). The
Notch ligand Dll4 (Delta like 4, mbDll4) is specifically
expressed on endothelial cells of the arteries, arterioles and
capillaries (Benedito and Duarte, 2005) (Gale et al., 2004) and
also on the perivascular stromal cells, and pericytes (Schadler
et al., 2010). The specific expression of Dll4 in the vascular
niche, known to exert an essential role in HPCs maintenance,
attracted our interest for the role of the Dll4/Notch pathway in
the bone marrow HPCs homeostasis. We have previously
reported that themembrane-bound Notch ligand Dll4 (mbDll4)
counteracts the proliferation of human cord blood CD34+ cells
induced by cytokines and preserves a high LTC-IC potential in
output CD34+ cells, even in cells having performed a similar
number of divisions, indicating that LTC-IC retention was
mediated by mechanisms independent of the mitotic history
(Lauret et al., 2004) (Lahmar et al., 2008).
Here we report that Dll4 counteracts the proliferation of
murine HPCs such as Lin−Sca+c-Kit+ (LSK) cells, by keeping a
higher fraction of cells in the G0 state. This event was
correlated with a downmodulation of some key cell cycle
genes transcription such as D-CYCLINS. Furthermore, Dll4
limits the loss of the short-term reconstitutive potential, as
assessed by in vivo reconstitution assay, correlated withsuch asBMI1,HOXB4,GATA2 andC-MYC aswell as PUMILIO1 and
-2, two RNA-binding proteins previously identified as regulators
involved in stem cell proliferation in invertebrates. Altogether,
these data reinforce the major role of the Notch ligand Dll4 in
the vascular niche as a new player in HPCs maintenance.
Materials and methods
Mice
C57BL/6-Ly5.2, C57Bl/6-Ly5.1 (8–20 weeks old) were pur-
chased from Janvier CERJ (Le Genest-St-Isle, France). All
mice weremaintained in the Gustave-Roussy Institute facilities
under specific pathogen-free conditions.
Cytometric analysis
Lineage negative Sca-1 and c-Kit positive (LSK) cell purifica-
tion was performed as described by Spangrude and colleagues
(1988). In some experiments, Lin− and LSK cells were analysed
using biotinylated mAbs raised against differentiation markers
(Gr-1 clone RB6-8C5, Mac-1 clone M1/70, B220 clone RA3-6B2,
CD3 clone 145-2C11 and Ter-119,mouse lineage panel, Becton
Dickinson), revealed using streptavidinmolecules, and stained
with anti-Sca-1 mAb, (clone E13-161.7) anti-c-Kit mAb (clone
2B8), and anti-CD150 mAb (clone TC15-12F12.2). Biotinylated
CD41 (clone ebioscienceMWReg30) and CD48 (HM48-1) mAbs
were added in the lin cocktail to analyse the SLAM phenotype.
CD44 (clone 515) and CD25 (clone M-A2-51) mAbs were used to
phenotype lymphoid precursors. Notch receptor expression
was performed using anti-Notch 1 (clone HMN-12), anti-Notch
2 (clone HMN2-35) and anti-Notch 4 (clone HMN4-14) antibod-
ies (Biolegend). Isotype-matched antibodies were used as
controls. Sorting of the LSK fraction was performed using a
FACSvantage or an Aria III (Becton-Dickinson).
Culture experiments
Each of the S17 stroma cells (C/S17 and mbDll4/S17) was
obtained and cultured as previously described (Lauret et al.,
2004). LSK cells were cultured in 24-well plates coated with
confluent C/S17 or mbDll4/S17 in α-MEM containing 10% FCS
(Stem Cell Technology, Vancouver, Canada). The following
cytokines were added: murine Stem Cell Factor [muSCF],
human Flt-3 ligand [HuFlt3-L], human interleukin-6 [IL-6],
each at 100 ng/mL, and human interleukin-11 [IL-11] at
10 ng/mL. Some LSK cells were cultured on immobilised
Dll4Fc (10 μg/ml) on plastic as previously described (Lauret et
al., 2004), irrelevant human IgG1 served as a negative control.
Some cultures were performed in the presence of 10 mM DAPT
(a gamma-secretase inhibitor: N-{N-(3,5-difluorophenacetyl)-
L-alanyl}-S-phenylglycine-t-bytyl ester; Calbiochem, San Diego)
or DMSO as vehicle.
Cell-cycle analysis
Carboxyfluorescein succinimidyl ester (CFSE) staining
Before coculture, sorted LSK cells were incubated with
CFSE 1 μM for 10 minutes at 37 °C allowing protein staining.
433Delta-4/Notch pathway retains the HPCs potentialCell divisions were analysed on a FACSort cytometer after
2 days in culture (Becton Dickinson).
Ki-67 analysis. Ki67 is a nuclear antigen associated with
cell proliferation and is present throughout the active cell
cycle (G1, S, G2 and M phases) but absent in resting cells
(G0). Cells were labelled with APC-anti-CD45 mAb, incubat-
ed with a cytofix–cytoperm solution (Becton Dickinson),
washed with a permwash solution (Becton Dickinson), and
finally incubated with FITC-anti-Ki-67 mAb and DAPI before
LSR cytometer analysis (Becton Dickinson).
Pyronin/Hoechst analysis. FITC-anti-CD45 mAb labelled
cells were incubated with 10 μg/ml Hoechst 33342 and
1 μg/ml Pyronin Y (RNA dye) (Sigma Chemical Co., St Louis,
MO) at 37 °C for 45 minutes in Hanks balanced salt solution
(HBSS) medium supplemented with 2 mM Hepes, 10% FBS
and 1 mg/l glucose (Gothot et al., 1997).
Long-term culture-initiating cell (LTC-IC) and
CFC assay
Long-term culture-initiating cell (LTC-IC) assay was performed
as described by Sutherland and colleagues (Sutherland et al.,
1989). The cultures were recovered after 5 weeks and assayed
for the presence of myeloid culture colony-forming unit
(CFU-C) using a methylcellulose medium (M3234; Stem Cell
Technologies, Vancouver, BC, Canada) supplemented with
cytokines. After 7 to 10 days of growth at 37 °C, colonies were
scoredwith an invertedmicroscope based on theirmorphology.
Long-term competitive repopulation assay
C57Bl/6 (Ly5.2) mice were used as recipients, whereas LSK
cells were prepared from C57Bl/6 (Ly5.1) donors. Lethally
irradiated recipients were cotransplanted with 1.5 × 105
Ly5.2 BM cells together with various amounts of cells exposed
to S17 stroma or immobilised Dll4Fc protein for 7 days,
injected into the retro-orbital sinus of mice. Haematopoietic
reconstitution was assessed at 4 and 16 weeks after trans-
plantation through analysis of blood or bone marrow respec-
tively. Analysis of the presence of CD45.1+ cells in blood and
bone marrow of reconstituted mice at 4 and 16 weeks after
transplant was performed using flow cytometry with a cut-off
0.1% CD45.1+ (donor) cells for at least 105 analysed cells (FACS
Sort). Animals displaying greater than 0.1% of CD45.1+ positive
cells were considered as positive for repopulation.
Microarray
Total RNAs from sorted cell populations were isolated using
the RNAplus kit (Qbiogene) and further amplified using the
MessageAmp aRNA kit (Ambion, Austin, TX). The integrity of
the RNA samples was verified using an Agilent Bioanalyzer
(Palo Alto, CA). The cDNAs were labelled and hybridised to
the murine microarray manufactured in CEA microarray
platform as described (Godefroy et al., 2004). Slides were
scanned with a Genepix 4000 microarray scanner (Axon
Instruments, Molecular Devices, Sunnyvale, CA). Images
were processed to acquire Cy5 and Cy3 fluorescence
intensities for each hybridised spot using Genepix Pro 4.0software (Axon Instruments). Spots or areas of the array with
obvious blemishes were flagged and excluded from subse-
quent analysis. Result files were imported into GeneSpring
6.1 software (Silicon Genetics, Agilent) for further analyses.
To eliminate dye-related artefacts in 2-colour experiments,
intensity-dependent Lowess normalisation was performed.
The results represent the average of 8 independent measures
and were deposited in the Gene Expression Omnibus (GEO)
database (http://www.ncbi.nlm.nih.gov/geo/) with the GSE
5135 accession number. Differentially expressed genes were
obtained by analysis of variance using ANOVA parametric test
(p b 0.01) followed by Benjamini and Hochberg multiple test
correction. For stringent comparisons, only probes with a
hybridization value in at least 6 of 8 replicateswere considered
for further analysis.Quantitative reverse-transcriptase (RT)-PCR
Total RNA was extracted from cells using the Trizol reagent
(InVitrogen). Synthesis of first-strand cDNAs was performed
using oligo(dT) and Superscript II reverse transcriptase
(Invitrogen). PCR was performed using SYBRGreen PCR
Master Mix (PE Applied Biosystems, Foster City, CA). PCR
was monitored with a GeneAmp 5700 sequence detection
system (PE Applied Biosystems). Quantification was per-
formed using the Ct values method. The primers used are
indexed in Supplementary data Table S1.Statistical analysis
All measurements were performed at least three times.
Continuous variables were analysed using Student's t-test
for paired values. The measured values were expressed as
mean ± SEM. p-Values of less than 0.05 were considered to
be statistically significant.Results
Dll4 maintains a fraction of HPCs out of the cycle
We first examined Notch receptor expression on murine
bone marrow HPCs. The majority of LSK cells expressed the
Notch 2 receptor (79.7 ± 1.8%), while few of them expressed
Notch 1 (29.1 ± 9.3%) and Notch 4 (13.9 ± 3.0%) (Figure S1).
Our data confirmed the major role of Notch 2 in governing
the rate of generation of mouse long- and short-term
repopulating stem cells, as previously described (Varnum-
Finney et al., 2011; Corselli et al., 2013). To assess mbDll4
activities on murine HPCs, LSK cells were cultivated with
cytokines on control (C) and mbDll4 stromas (mbDll4). After
a 7-day culture, the fold increase in total cell number was
significantly reduced (1200 ± 90 onto C versus 600 ± 72 onto
mbDll4, p b 0.05, Fig. 1A), indicating that mbDll4 reduced
total cell expansion. Apoptosis analysis did not reveal any
difference in the percentage of apoptotic cells between C
and mbDll4 population neither at day 2 (12 ± 5% for C versus
13 ± 4% for mbDll4 culture) nor at 7 days of culture (data not
shown), thus precluding a potential role of apoptosis in the
reduction of cell expansion upon mbDll4 stimulation.
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Figure 1 mbDll4 reduces cell proliferation by keeping a fraction of cells in G0. (A) Fold increase in total cell number. Sorted BM LSK
cells were cultivated in 24-well plates (500–1000 cells per well) coated with C or mbDll4 stromas in the presence of mSCF, hFlt3-L,
hIL-6 and mIL-11. Haematopoietic cells were harvested at day 7 and the fold increase in total cell number was calculated by dividing
the number of output cells at day 7 by the number of input LSK cells, * = p b 0.05. (B) High resolution tracking of cell division.
Carboxyfluorescein diacetate succinimidyl ester-labelled (CFSE) LSK cells were cultured in wells coated with C or mbDll4 stroma in
the presence of the same cocktail of cytokines. Flow cytometry analysis of CFSE+ cells was made after 2 days of culture. Percentage
means represent the area of each peak (FACS analysis of one representative experiment). The percentages represent the mean of 3
experiments. Dashed lines illustrate single divisions, which are differentiated by losing CFSE fluorescence at each division. (C)
Distribution of cells in G0 versus G1 and S/G2M phase of the cell cycle using Ki-67 and DAPI staining. Sorted BM LSK cells cultivated as
previously described were harvested at day 2, and were stained with Ki-67 Ab (proliferating cells) and DAPI (DNA dye). Cells residing
in G0 appear at the bottom of the G0/G1 peak, G1 cells are in the upper part and S/G2/M cells are at the right hand side of the G1
peak as indicated. (D) Distribution of cells in G0 versus G1 and S/G2M phase of the cell cycle using Hoechst and Pyronin staining.
Sorted BM LSK cells were cultivated as previously described. Cells harvested at day 2 were stained with Pyronin (proliferating cells)
and Hoechst (DNA dye). Cells residing in G0 appear at the bottom of the G0/G1 peak, G1 cells are in the upper part and S/G2/M cells
are at the right hand side of the G1 peak as indicated. Results are presented as the mean ± SEM in triplicate assays. Data are
expressed as mean ± SEM, n = 3, p b 0.05.
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Figure 2 Analysis of gene expression of regulators involved in
cell cycle in response to Dll4. Quantitative real time PCR was
performed to validate the microarray data. PCR amplifications
were carried out in triplicate on RNA prepared from LSK cells
exposed or not to Dll4Fc for 12 h (3 independent experiments).
The mRNA expression of each gene was normalised to that of
TF2D mRNA. The final ratios, expressed as a fold change, were
generated by comparing expression levels of LSK cells exposed
to Dll4Fc compared to control cells. Results are presented as the
mean ± SEM in triplicate assays, p b 0.05.
435Delta-4/Notch pathway retains the HPCs potentialLabelling of cells with carboxyfluorescein diacetate
succinimidyl ester to simultaneously monitor cell divisions
at 2 days of culture when both populations were homog-
enous, still displaying 90% Lin− cells (data not shown),
showed that the proportion of cells not dividing or dividing
once was significantly higher in the population exposed to
mbDll4 as compared to C (3 ± 0% for C versus 6 ± 0% for
mbDll4 culture at 0 division, p = 0.02 and 15 ± 0% for C
versus 19 ± 0% for mbDll4 culture at one division, p b 0.05),
while the proportion of cells having performed 4 divisions was
lower in the population exposed to mbDll4, as compared to
cells grown on C (18 ± 2% for C versus 12 ± 2% for mbDll4
culture, p b 0.05, Fig. 1B).
To precisely decrypt the modifications in the cell cycle
and separate the G0 and G1 states, we used Ki-67/DAPI
staining to estimate the frequencies of G0 (Ki67−; 2N DNA
content), G1 (Ki-67+; 2N DNA content), and S/G2/M (Ki-67+;
N2N DNA content). According to these markers, we found a
higher proportion of LSK cells exposed to mbDll4 in the G0
state (7 ± 1% for LSK exposed to C versus 13 ± 2% for LSK
cells exposed to mbDll4 culture, p b 0.05), with a significant
modification in the proportion of cells in S/G2/M (47 ± 2%
for C versus 37 ± 3% for mbDll4, p b 0.05, Fig. 1C). These
modifications in the cell cycle were confirmed by Pyronin-Y
(PY) and Hoechst 33342 (Ho) staining (Fig. 1D). These data
showed that mbDll4 counteracts the stimulatory prolifera-
tive effects of cytokines by maintaining out of the cycle a
higher fraction of LSK cells.
Dll4 downmodulates expression of D-cyclins
To identify potential Dll4-dependent genes implicated in the
cell cycle, we used a chimeric Dll4Fc protein for a stimulation
set up independent of the stroma cell context. We first
confirmed the antiproliferative activity of Dll4Fc on LSK cells.
When cultured on immobilised Dll4Fc, HPCs displayed a reduced
cell expansion as compared to control populations at day 7 of
the culture (Figure S2A). Furthermore, analysis at day 2 of RNA/
DNA contents by Pyronin-Y (PY) and Hoechst 33342 (Ho) staining
revealed a higher proportion of cells in the G0 state (6 ± 2% for
C versus 14 ± 5% for Dll4Fc, p b 0.05, Figure S2B), with a
significant modification in the proportion of cells in S/G2/M
(49 ± 3% for LSK cells exposed to C versus 37 ± 6% for LSK cells
exposed to Dll4Fc, p b 0.05) (Figure S2B), as previously showed
for mbDll4. Next, we assessed the expression of some key
downstream cell cycle target genes 12 h after exposure to
Dll4Fc (before their first division). As shown in Fig. 2, we
observed a transcriptional upregulation of p130 (1.33 ± 0.11,
p = 0.02), E2F4 (2.4 ± 0.18, p = 0.02) and Rb (2.7 ± 0.41, p =
0.04) genes and a downregulation of CYCLIN-D1 (0.26 ± 0.01,
p = 0.02), CYCLIN-D2 (0.27 ± 0.02, p = 0.03) and CYCLIN-D3
genes (0.38 ± 0.05, p = 0.04) after exposure to Dll4Fc. In
contrast, the level of transcriptional expression of p18INK4c,
p19INK4d, p21Cip1/Waf1, p27Kip1, p57Kip2, cdk1, cdk4, cdk6,Dmtf1,
p107, CYCLIN-E1 and CYCLIN-E2 genes was not modified after
exposure of HPCs to Dll4Fc (data not shown).
Dll4 limits the loss of HPCs primitive potential
We also examined the effects of mbDll4 on the LSK cells by
following the proportion of LSK cells throughout a 7-dayculture on C and mbDll4 stromas. A progressive decline in
the % of LSK cells on the C stroma compared to the mbDll4
stroma became significant at day 2, and this difference
increased progressively to reach 5-fold more LSK cells on
mbDll4 stroma at day 7 (7 ± 4% for C versus 38 ± 0% on
mbDll4, p b 0.05, Fig. 3A and B). We did not notice any
significant difference in the proportion of the different
lineages among Lin+ cells, indicating that in our culture
conditions, mbDll4 did not favour differentiation toward a
particular myeloid lineage (Figure S3A). Nevertheless, we
noticed at day 7 the appearance of a small number of CD44+/
CD25+ (markers of early T cell differentiation) cells upon
mbDll4 stimulation, as observed in previous studies (Figure
S3B) (Dallas et al., 2007).
To further characterise the primitive potential of cells
generated after 7 days of culture on both stromas, we
monitored their in vitro CFC and LTC-IC as well as their in
vivo repopulating activity. Cells cultured on mbDll4 main-
tained a higher proportion of clonogenic colonies (48 ± 8 CFC
per 500 Lin− on C versus 68 ± 20 CFC per 500 output Lin−
cells on mbDll4, p b 0.05, Fig. 3C). The increased CFC
number was the result of a general increase in all types of
colonies (CFU-GM, BFU-E, and mixed colonies). Further-
more, colonies generated on mbDll4 displayed a larger size,
as compared to those derived from Lin− cells on C (data not
shown). The LTC-IC potential of output LSK cells generated
on mbDll4 was preserved at day 7, compared to the one of
input bone marrow LSK cells (18 ± 4 LTC-IC-derived CFC/
1000 for output LSK versus 24 ± 0.5 for 1000 output LSK cells
from mbDll4 culture), while this potential was strongly
impaired in output LSK cells generated onto C (1.9 ± 0.1
LTC-IC-derived CFC/1000 output LSK cells, p = 0.03, Fig. 3D).
This leads to a strongly enhanced expansion of LTC-IC-derived
CFC (251 ± 7 LTC-IC-derived CFC for C versus 4825 ± 110
LTC-IC-derived CFC for mbDll4 from 1000 input LSK cells,
p b 0.05, Fig. 3E).
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Figure 3 mbDll4 limits the loss of the in vitro primitive potential. LSK cells were cultivated on C and mbDll4 stromas in the
presence of mSCF, hFlt3-L, hIL-6 and mIL-11. (A) LSK cell maintenance. Cells harvested at the indicated days throughout the culture
were labelled to identify the percentage of LSK cells in the total nucleated cell population. (B) LSK cell analysis after 7 days. FACS
profiles of output LSK cells in one representative experiment (out of three) after 7 days of culture. (C) CFC potential of Lin− cells. Five
hundred sorted Lin− cells at day 7 were cultured in methylcellulose, and the number of erythroid (BFU-E), myeloid (CFU-GM) and
mixed colonies was measured after 7 days. Results are expressed as mean ± SEM of ten different experiments, each performed in
triplicate, * = p b 0.05. (D) LTC-IC potential of LSK cells. Two hundred input and output LSK cells from each condition were cultured
for 5 weeks on MS-5 cells, and cells from each well were then plated in methylcellulose and the number of CFC-derived LTC-IC was
counted after 7 days (mean ± SEM of four independent experiments, * = p b 0.05). (E) Expansion of LTC-IC derived CFC. Histogram
represents the number of LTC-IC derived CFC per 1000 input LSK cells. The total number of LTC-IC-derived CFC cells was calculated
using the total cell count, and the percentages of LSK cells. Data are expressed as mean ± SEM, n = 3, * = p b 0.05.
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the short-term reconstitution in the peripheral blood (4 weeks),
and the long-term in the bone marrow (N16 weeks) (Fig. 4 and
Figure S4). To cast off the expansion difference between
control and mbDll4 cultures, we injected all the progeny of
Ly5.1 LSK cells (ranging from 10 to 200 LSK seeded cells) grown
for 7 days on C and mbDll4, independently on the number of
cells grown in these two conditions, together with a fixed
number of Ly5.2 bone marrow competitor cells into irradiated
Ly5.2 recipients. While no chimerism was detected in mice
infused with cells grown onto C stroma at 4 or 16 weeks, 14 to
40% of mice were chimeric at 4 and 16 weeks with cells grown
onto mbDll4 stroma (Fig. 4A), with a chimerism dependent on
the amount of cells injected (from 0.06 ± 0.03 for 10 LSK cells
to 2.2 ± 0.9 for 200 LSK cells, chimerism at 4 weeks with cells
grown ontombDll4 stroma, Fig. 4B).When analysed at 16 weeks
post-transplantation, low levels of bone marrow cell chimerism(ranging from 0.1 to 1%, data not shown) were observed in mice
injected with the progeny of 10 to 200 LSK cells cultivated onto
mbDll4,while no chimerism could be detected formice injected
with the progeny of control LSK cells. These data indicated that
exposure to mbDll4 limits significantly the loss of the in vivo
reconstitutive potential at least in short term analysis.
To confirm the implication of Notch signalling in mbDll4
activity, we analysed the requirement of the γ-secretase
complex, which is an essential effector in the Notch signalling
pathway. When LSK cells were cultured on mbDll4 for 7 days in
the presence of DAPT (an inhibitor of the γ-secretase), cell
expansion was restored (857 ± 88 for cells onto mbDll4 in the
presence of DAPT versus 298 ± 48 for cells cultured on mbDll4
with DMSO, Figure S5A), and the maintenance of a high
proportion of LSK cells onmbDll4 was abrogated (4 ± 1 for cells
onto mbDll4 in the presence of DAPT versus 26 ± 5% for cells
cultured onto mbDll4 with DMSO, respectively, Figure S5B).
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Figure 4 mbDll4 limits the loss of the short-term reconstitution potential. In vivo reconstitution potential. Progeny of 10 to 200
sorted Ly5.1 LSK cells cultivated in the conditions previously described, were harvested at day 7, mixed with fresh 1.5 × 105 Ly5.2 BM
cells and transplanted into lethally irradiated C57B6 Ly5.2 mice (5 to 8 mice per group). Analysis of the presence of CD45.1+ cells in
blood and bone marrow of reconstituted mice at 4 and 16 weeks after transplant was performed using flow cytometry with a cut-off
0.1% CD45.1 (donor)+ cells for at least 105 analysed cells (FACS Sort). Table A presents the frequency of reconstitution at 4 and
16 weeks after transplant, and panel B the average chimerism 4 weeks after transplant in recipient mice, * = p b 0.05.
437Delta-4/Notch pathway retains the HPCs potentialIdentification of downstream target genes modulated
by Dll4
To reveal new signalling pathways involved in the effects of
Dll4 on HPCs, we performed a differential transcriptomic
analysis of HPCs cultured for 6 or 12 h with or without
Dll4Fc. First, we confirmed the similarity of the HPCs
response between immobilised Dll4Fc and mbDll4. HPCscultured for 7 days on immobilised Dll4Fc maintained a
higher proportion of LSK cells (5 ± 2 for C versus 22 ± 7% for
Dll4Fc culture, p b 0.05, Figure S6A), retained a primitive
potential, evidenced by an LTC-IC potential identical to the
input cells, leading to an enhanced expansion of LTC-IC-
derived CFC (16 ± 3 for C versus 323 ± 19 for Dll4Fc culture,
p b 0.05, Figure S6B), and a higher in vivo reconstitution
potential when inoculated into irradiated mice (78% of
438 C. Catelain et al.chimeric mice at 16 weeks post-transplant for Dll4Fc cultures
versus 12% of chimeric mice for control cultures, Figure S6C).
Using the ANOVA parametric test (p b 0.01) and Benjamini
and Hochberg multiple testing correction, we found 559
modulated probes for Dll4Fc cultures and 64modulated probes
for control cultures after 12 h of culture versus non-cultured
LSK cells. To provide a biological interpretation of these gene
expression modifications, we looked for statistical significance
of the enrichment of particular functional categories using
Ingenuity pathways analysis (IPA) and DAVID resources (http://
david.abcc.ncifcrf.gov/home.jsp), focusing particularly on
Gene Ontology (GO) Biological Process terms. We found that
most of the genes were included in three significant GO
categories: “Cell Growth and Proliferation,” “Cell Cycle
Process” and “Translation Process” (Figure S7). Very few
genes were modulated at 6 h (data not shown). Interestingly,
one of the upregulated genes at this early time was HOXB4
(1.8 ± 0.4, p = 0.01). Changes in gene expression observed at
12 h were confirmed by RT-qPCR on a series of selected genes
encompassing all the scale of modulations (Fig. 5), validating
thus the microarray data. Genes such as GATA2 (2.4 ± 0.4, p =
0.04), HES1 (4.7 ± 1.8, p = 0.01), BMI1 (5.1 ± 2.3, p = 0.01),
EED (1.7 ± 0.2, p = 0.002), and C-MYC (13.9 ± 1.5, p = 0.007)
were already known to be involved in stem cell self-renewal
(Amsellem et al., 2003; Ezoe et al., 2002; Kunisato et al.,
2003; Iwama et al., 2004; Xie et al., 2013; Satoh et al., 2004;
Wilson et al., 2004). The chaperone HSP90 protein (1.4 ± 0.1,
p = 0.01) and the transcription factor MNT (6.9 ± 1.2, p =
0.03) were not previously identified as involved in this
process. In addition, the post-transcriptional repressor
gene PUMILIO2 (PUM2) identified in invertebrates and
previously described in other models to be involved in
stem cell fate or expansion (Lee et al., 2007; Sada et al.,
2009), was also found highly upregulated (6.8 ± 1.1, p =
0.04). Therefore, we measured the transcription levels of
PUMILIO1 (PUM1) (absent in the microarray) by RT-qPCR.
The results show that PUM1 transcription was also upreg-
ulated in response to Dll4 (2.9 ± 0.7, p = 0.04), suggesting
that both mammalian PUMILIO proteins might potentially
play an important role in Notch-ligand Dl14-dependent cellG
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Figure 5 Analysis of gene expression of regulators involved in se
performed to validate the microarray data. PCR amplifications were
or not to Dll4Fc for 12 h (3 independent experiments). The mRNA exp
final ratios, expressed as a fold change, were generated by comp
controls. Results are presented as the mean ± SEM in triplicate assadevelopment and differentiation. We also confirmed the down
regulation of Osteopontin (OPN) (0.3 ± 0.04, p = 0.01) and the
CCL12 chemokine (0.3 ± 0.06, p = 0.04).
Discussion
In accordance with our previous work performed on human
CD34+ CD38low cord blood cells (Lauret et al., 2004), mbDll4
reduces murine bone marrow HPCs cell expansion correlated
with the retention of their primitive potential in vitro. The
present study further reveals that the reduced cell prolifera-
tion was mainly due to the maintenance of a higher proportion
of HPCs in the G0 state. It also shows that cell culture on
mbDll4-expressing stroma limits the loss of their short term
repopulating capacity in vivo, and finally leads to the iden-
tification of the gene signature of HPCs in response to Notch/
Dll4 signalling.
Maintenance of a higher proportion of LSK cells out
of the cycle
The vascular niche has been demonstrated to maintain HPCs
in vivo (Butler et al., 2010). Endothelial and perivascular
cells play a key role as main producers of SCF (Ding et al.,
2012), and CCL12 (Ding and Morrison, 2013) in the bone
marrow. Furthermore, both of them support HPCs mainte-
nance ex vivo (Butler et al., 2010); (Corselli et al., 2013).
The maintenance of quiescence is also a key feature for
regulating HPCs homeostasis. Using the signalling lympho-
cyte attractant molecule (SLAM) family markers to identify
quiescent HPCs, several studies report that most quiescent
HPCs are localised adjacent to blood vessels in the bone
marrow (Ding et al., 2012; Kiel et al., 2005; Kiel et al.,
2007). Only a few of the external factors governing HSCs
quiescence in the vascular niche have been identified among
which Tie2/Angiopoietin-1 play a major role (Arai et al.,
2004). Dll4 has been shown to be expressed in endothelial
and perivascular cells (Schadler et al., 2010); (Shutter et al.,
2000). We have previously shown that the exposure ofPum-2 Mnt Opn CCL12 C-Myc mi-1 
lf-renewal in response to Dll4. Quantitative real time PCR was
carried out in triplicate on RNA prepared from LSK cells exposed
ression of each gene was normalised to that of TF2D mRNA. The
aring expression levels of cells exposed to Dll4Fc compared to
ys, p b 0.05.
439Delta-4/Notch pathway retains the HPCs potentialhuman CD34+ cells to mbDll4 maintains a high proportion of
cells in the G0/G1 phase without distinguishing the G0 phase
from the G1 phase. The present data further revealed a higher
proportion of HPCs in the G0 phase, in spite of our cell culture
conditions based on strong cytokine activation, suggesting
that Dll4-expressing cells participate to the maintenance of
HPCs out of the cell cycle. To our knowledge, Dll4 is the only
Notch ligand described as keeping HPCs out of the cycle.
To get insight into the mechanisms of Dll4 activity, we
examined the transcriptional modulation of some cell cycle
genes. The D-cyclin family, CYCLIN-D1, CYCLIN-D2, and
CYCLIN-D3 genes were all transcriptional expressed, albeit
at different levels, in HPCs (Passegue et al., 2005). CYCLIN
D1−/−D2−/−D3−/− embryos displayed a reduced numbers of
foetal HPCs, with impairment in their ability to proliferate,
revealing a unique requirement for the D-CYCLINS in the
haematopoietic lineage (Kozar et al., 2004). The transcrip-
tional downmodulation of the 3 D-CYCLINS genes observed in
response to Dll4 is therefore in complete agreement with the
key role of D-CYCLINS in HPCs proliferation. E2F4, which can
bind to all 3 pRB family members to form the majority of
cellular pRB family complexes, has been proposed to play a
critical role in coordinating cell cycle exit (Trimarchi and
Lees, 2002). The retinoblastoma (Rb) family of transcrip-
tional repressors, including the pRb, p107 and p130 proteins,
restricts cell cycle entry by regulating E2F gene transcription
of positive cell cycle regulators. Conditional deletion of all
three Rb family members in adult mice resulted in a robust
cell-intrinsic myeloproliferation phenotype, with an increase
in HPCs proliferation, and severe defects in self-renewal
(Viatour et al., 2008). Therefore, the transcriptional upregu-
lation of E2F4 and Rb genes in response to Dll4 is consistent
with their role in the cell cycle. Taken together, these findings
indicate that Cyclins D and Rb family members may play a
critical role in the activity of the Dll4/Notch pathway for the
maintenance of the quiescent state.mbDll4 limits the loss of HPC potential in vitro and
in vivo
Exposure of LSK cells to mbDll4, not only preserves their in
vitro CFC and LTC-IC potential, but also limits the loss of the
in vivo short-term reconstitutive potential, as compared to
LSK cells cultured in control conditions. A chimeric Delta1Fc
(Dll1Fc), immobilised on the plastic, thus mimicking the
membrane-bound form, was previously used, showing an
improvement of the long-term reconstitutive potential of BM
LSK cells or human cord blood CD34+ cells cultivated with
Dll1 (Varnum-Finney et al., 2003); (Delaney et al., 2010).
Exposure of LSK cells to mbDll4 showed a limited in vivo
long-term reconstitutive potential, despite preserving the in
vitro CFC and LTC-IC potential. We suggest that Dll4
contributes to the short-term bone marrow reconstitution,
thus allowing rapid recovery of homeostasis in response to
stress.
Exposure of LSK cells to Dll4 was correlated with an
enhanced transcriptional expression of HES1, the well-known
Notch target gene. A recent study suggests that γSE complex/
Notch signalling controls early HPC commitment decisions in
bone marrow, partly through the Hes family of transcriptional
repressors (Klinakis et al., 2011). Furthermore, overexpressionof HES1 in LSKCD34− cells leads in vivo to an accumulation of
the primitive SP cells and LSKCD34− cells in marrow of re-
cipient mice, while maintaining the production of the dif-
ferentiated blood cells (Kunisato et al., 2003). However, its
role on the cell cycle is still controversial: an overexpression of
HES1 in human CD34+ cells reduced their proliferation (Yu et
al., 2006), while a comparable study led to an increase in the
incorporation of BrdU in HES1-overexpressing cells, with a
reduction in apoptosis and an increase in their capacity to
expand in NOD-SCID mice (Shojaei et al., 2005). Different
levels of HES1 expression may be at the origin of these
contrasting effects.
To identify the downstream mechanisms involved in Dll4
activity, we have compared the transcriptional response of
HPCs exposed to Dll4 to control HPCs. Our comparative
study of the transcriptome has provided us with a skeleton
of an answer by revealed upregulation of some genes
already identified to be implicated in the regulation of
HPC self-renewal such as BMI1 (Iwama et al., 2004), HOXB4
(Amsellem et al., 2003), EED (Xie et al., 2013), GATA2 (Ezoe
et al., 2002) and C-MYC (Satoh et al., 2004); (Wilson et al.,
2004). Transcriptional screening has also highlighted new
up-regulated candidate genes, PUMILIO1 and -2, down-
stream of the Dll4/Notch signalling pathway. Among the
post-transcriptional regulators of stem cells, PUM proteins,
which belong to the evolutionary highly conserved family of
PUF proteins, have been shown to be central for the
maintenance of germinal and somatic stem cells in inverte-
brate. They are able to bind specific motifs mainly present
in the 3′-untranslated region (3′UTR) of target mRNAs, thus
favouring sets of mRNA's to be degraded or kept untranslat-
ed. The fact that PUF genes are targets of Notch signalling in
HPC was previously observed in Caenorhabditis elegans
germline stem cells, the expression of the FBF2 gene being
under the control of GLP-1/Notch signalling (Lamont et al.,
2004). Activation of PUF genes by Notch signalling in both C.
elegans germ stem cells and murine HPCs enforces the link
between these two major mechanisms regulating stem cell
mitoses. However the implication of PUM proteins in the
function of mammalian stem cells has been rarely ad-
dressed, and only few reports have highlighted a possible
role of PUM2 and two invertebrate PUM partners (NANOS
and TRIM32) in the primitive potential of murine embryonic
and adult spermatogonial and neural stem cells, respec-
tively (Lee et al., 2007; Sada et al., 2009); (Schwamborn et
al., 2009). Interestingly, a connection between PUF pro-
teins and another main regulator of HSCs maintenance such
as HOXB4/C4 was stressed through a previous study (Auvray
et al., 2012). Comparative transcriptome analyses of human
CD34+ cells subjected or not to HOXB4 or HOXC4 genes have
revealed that both homeoproteins upregulate PUM1 and
PUM2 encoding genes. The link between Pumilio and Dll4/
Notch pathway in the function of HPCs will be further
investigated.Conclusion
Our observations strongly indicate that the vascular Notch/
Dll4 ligand exerts a dormant activity on HPCs, distinct from
other Notch ligands, and displays clear-cut positive effects
on the maintenance of the primitive functions of murine
440 C. Catelain et al.HPCs in culture. Furthermore, the link between Pumilio and
Dll4/Notch pathway in the function of HPCs is a new
understanding step in the mechanism of the Notch signalling
pathway. These newly identified factors, PUM1 and PUM2,
could be implicated in the expansion and maintenance of
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